OCT-derived coronary calcified nodules as a predictor of high-risk patients.
Takashi Akasaka, Takashi Kubo
https://pubmed.ncbi.nlm.nih.gov/32855116/Actively Recruiting
Led by Spanish Society of Cardiology · Updated on 2026-04-30
50
Participants Needed
6
Research Sites
52 weeks
Total Duration
This research aims to compare two techniques for treating calcified coronary nodules in patients with atherosclerotic coronary artery disease. These nodules are associated with worse outcomes because they are difficult to properly dilate before stent implantation. The study is a multicenter, prospective, randomized clinical trial including patients eligible for revascularization through percutaneous coronary intervention PCI who have calcified nodules identified by optical coherence tomography OCT. Participants will be randomly assigned to receive lesion preparation using either orbital atherectomy OA or intravascular lithotripsy IVL. Orbital atherectomy uses a diamond-coated orbital crown to modify calcified plaque by abrasion and creating microfractures. Intravascular lithotripsy uses a balloon that delivers sonic waves to fracture calcium. After lesion preparation, all patients will undergo PCI with drug-eluting stent implantation. The study includes a follow-up period of 12 months after the procedure. During the study, participants will be assessed using OCT imaging to measure stent expansion and calcium modification. Researchers will evaluate procedural success, strategy success, and incidence of adverse clinical events over 12 months. Various measurements, including stent area, fracture evidence, and cardiovascular events, will be monitored to compare the two techniques. Safety and effectiveness outcomes will be collected throughout the follow-up period.
CONDITIONS
Orbital Atherectomy vs Intravascular Lithotripsy for the Treatment of Calcified Coronary Nodules (ORBIT-SHOCK).
Á
Ángel Sánchez-Recalde, MD, PhD.
L
Luis Manuel Domínguez-Rodríguez, MD.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Spanish Society of Cardiology
Lead Sponsor
Abbott
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Single procedure visit
Participants undergo lesion preparation using either orbital atherectomy or intravascular lithotripsy followed by percutaneous coronary intervention with drug-eluting stent implantation.
1 visit (in-person)
Duration - 12 months
Participants are monitored for 12 months after the procedure to assess adverse clinical events and stent outcomes using imaging and clinical evaluations.
Regular follow-up visits
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Takashi Akasaka, Takashi Kubo
https://pubmed.ncbi.nlm.nih.gov/32855116/Niels R Holm, Lene D Andreasen, Omeed Neghabat...
https://pubmed.ncbi.nlm.nih.gov/37634149/Doosup Shin, Ali Dakroub, Mandeep Singh...
https://pubmed.ncbi.nlm.nih.gov/38946577/Takao Sato, Mitsuaki Matsumura, Kei Yamamoto...
https://pubmed.ncbi.nlm.nih.gov/37164599/Akiko Maehara, Ori Ben-Yehuda, Ziad Ali...
https://pubmed.ncbi.nlm.nih.gov/26585621/Christiaan Vrints, Felicita Andreotti, Konstantinos C Koskinas...
https://pubmed.ncbi.nlm.nih.gov/39210710/Brigitta C Brott
https://pubmed.ncbi.nlm.nih.gov/37164600/Roxana Mehran, Sunil V Rao, Deepak L Bhatt...
https://pubmed.ncbi.nlm.nih.gov/21670242/Naotaka Okamoto, Yasuyuki Egami, Hiroaki Nohara...
https://pubmed.ncbi.nlm.nih.gov/37704299/Ziad A Ali, Ulf Landmesser, Akiko Maehara...
https://pubmed.ncbi.nlm.nih.gov/37634188/Spanish Society of Cardiology
Lead Sponsor
Abbott
Collaborating Sponsor